erythromycin ethylsuccinate has been researched along with Blennorrhea, Inclusion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandström, I | 1 |
| Kallings, I; Melen, B; Sandström, I | 1 |
| Ringertz, O; Sandström, I | 1 |
| Bishop, E; Grossman, M; Landers, D; Robbie, M; Schachter, J; Sweet, RL | 1 |
1 trial(s) available for erythromycin ethylsuccinate and Blennorrhea, Inclusion
| Article | Year |
|---|---|
Experience with the routine use of erythromycin for chlamydial infections in pregnancy.
Topics: Chlamydia Infections; Chlamydia trachomatis; Clinical Trials as Topic; Conjunctivitis, Inclusion; Drug Tolerance; Erythromycin; Erythromycin Ethylsuccinate; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Uterine Cervical Diseases | 1986 |
3 other study(ies) available for erythromycin ethylsuccinate and Blennorrhea, Inclusion
| Article | Year |
|---|---|
Neonatal conjunctivitis caused by Chlamydia trachomatis.
Topics: Bacteriological Techniques; Conjunctivitis, Inclusion; Diagnosis, Differential; Erythromycin; Erythromycin Ethylsuccinate; Humans; Infant, Newborn; Microbial Sensitivity Tests | 1984 |
Neonatal chlamydial conjunctivitis. A long term follow-up study.
Topics: Conjunctivitis, Inclusion; Erythromycin; Erythromycin Ethylsuccinate; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male | 1988 |
Levels of erythromycin in tear fluid and serum in infants with conjunctivitis.
Topics: Chlamydia trachomatis; Conjunctivitis, Bacterial; Conjunctivitis, Inclusion; Erythromycin; Erythromycin Ethylsuccinate; Humans; Infant, Newborn; Staphylococcal Infections; Staphylococcus aureus; Tears; Time Factors | 1988 |